Immunovia AB Stock OTC Markets
Stocks
IMMVF
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -48.56% |
|
+9,900.00% | +9,900.00% |
| 06-15 | Immunovia Unveils New Data Ahead of Medicare Reimbursement Application | FW |
| 06-15 | Immunovia Announces New Performance Data for PancreaSure Ahead of Upcoming Application for Medicare Coverage | CI |
| Market Cap | 124M 12.9M 11.27M 10.4M 9.59M 18.07M 1.24B 18.47M 48.89M 608M 48.43M 47.37M 2.09B | P/E 2026 * |
-1.85x | P/E 2027 * | -4.62x |
|---|---|---|---|---|---|
| Enterprise Value | 57.31M 5.95M 5.2M 4.79M 4.42M 8.33M 573M 8.51M 22.54M 280M 22.33M 21.84M 965M | EV / Sales 2026 * |
17.9x | EV / Sales 2027 * | 2.91x |
| Free-Float |
89.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -48.56% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 year | 0.02 |  | 0.02 |
| 3 years | 0.02 | | 0.17 |
| 5 years | 0.02 | | 40 |
| 10 years | 0.02 | | 40 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 2023-04-28 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-04-28 |
| Chief Tech/Sci/R&D Officer | 54 | 2024-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2016-12-08 | |
Peter Andersen
CHM | Chairman | 69 | 2023-05-25 |
| Director/Board Member | 51 | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -48.56% | +9,900.00% | - | - | 12.9M | |
| -1.46% | +0.58% | +18.67% | -22.19% | 17.27B | |
| -6.27% | -7.01% | -0.84% | +86.72% | 1.57B | |
| -4.71% | -4.87% | -31.71% | -79.21% | 1.19B | |
| -1.34% | -5.93% | -37.82% | +13.91% | 999M | |
| -4.06% | +2.84% | -28.35% | -52.18% | 644M | |
| -7.46% | -4.05% | -40.62% | -56.91% | 532M | |
| -1.95% | -4.52% | +45.72% | -53.63% | 445M | |
| -1.26% | +0.64% | -54.33% | -58.41% | 382M | |
| +7.76% | +6.36% | -19.65% | -21.95% | 364M | |
| Average | -6.93% | -1.34% | -16.55% | -27.09% | 2.6B | |
| Weighted average by Cap. | -2.04% | -0.35% | +8.48% | -19.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 332K 290K 268K 247K 465K 31.97M 475K 1.26M 15.66M 1.25M 1.22M 53.9M | 17.3M 1.79M 1.57M 1.45M 1.33M 2.51M 173M 2.57M 6.8M 84.65M 6.74M 6.59M 291M |
| Net income | -91M -9.44M -8.25M -7.61M -7.02M -13.23M -909M -13.52M -35.79M -445M -35.46M -34.68M -1.53B | -82M -8.51M -7.43M -6.86M -6.32M -11.92M -819M -12.18M -32.25M -401M -31.95M -31.25M -1.38B |
| Net Debt | -67M -6.95M -6.07M -5.61M -5.17M -9.74M -669M -9.95M -26.35M -328M -26.11M -25.53M -1.13B | -74M -7.68M -6.71M -6.19M -5.71M -10.76M -739M -10.99M -29.11M -362M -28.83M -28.2M -1.25B |
Employees
17
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
- IMMVF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
